Open Source Health · Autoimmune
Over 100 distinct autoimmune conditions. All of them share a common thread: the immune system has lost tolerance and is attacking tissues it should protect. The triggers are identifiable. The conditions are not always irreversible. This is what the system almost never explains.
The diagnosis names the target.
The question that matters is
what pulled the trigger.
What Autoimmune Actually Is
The immune system's most important skill is discrimination: identifying what belongs in the body and what does not, and responding appropriately to each. Autoimmune disease is a breakdown of that discrimination. The immune system generates an attack against the body's own tissues. In rheumatoid arthritis, it attacks joint lining. In Hashimoto's, it attacks the thyroid. In lupus, it attacks multiple organs simultaneously. In type 1 diabetes, it attacks pancreatic beta cells. The target varies by condition. The underlying mechanism, loss of immune tolerance, is shared.
The prevailing model taught in medical school describes autoimmune disease as arising from a combination of genetic predisposition and an environmental trigger. The genetic piece is real but overstated. Having a genetic susceptibility does not guarantee autoimmune disease. Environmental factors are what convert susceptibility into activation. This is where the conversation about reversibility and management becomes productive.
Molecular mimicry is one of the primary mechanisms by which infections trigger autoimmune responses. Certain pathogens produce proteins that are structurally similar to human tissue proteins. The immune system generates antibodies against the pathogen. Those antibodies cross-react with the similar-looking human tissue. The infection resolves. The antibody attack on human tissue continues. This has been documented in rheumatic fever following streptococcal infection, Guillain-Barre syndrome following certain infections, and multiple sclerosis in some presentations.
The gut is the second primary mechanism. Intestinal permeability allows large food protein fragments and bacterial antigens to enter circulation. The immune system, encountering these antigens in contexts where it would not normally see them, generates an attack. Some of these antigens resemble human tissue proteins. The result is an immune response that began as a reaction to gut-derived antigens and becomes a self-directed attack on human tissue. The leaky gut to autoimmune pathway is supported by substantial evidence and remains almost entirely unaddressed in standard autoimmune disease management.
HLA gene variants increase susceptibility to specific autoimmune conditions. Carrying these variants is common and does not guarantee disease. The rate of concordance in identical twins for most autoimmune conditions is 25 to 50 percent, demonstrating that environmental factors determine whether genetics become expression.
Identified triggers include viral or bacterial infection (molecular mimicry), significant gut dysbiosis, intestinal permeability, heavy metal or toxin exposure, severe psychological stress or trauma, and hormonal shifts. Most people with autoimmune conditions can identify a preceding event if asked carefully enough.
Regulatory T cells normally suppress immune responses to self-antigens. When these fail, through exhaustion, infection, or disrupted gut immune education, the brake on self-attack is released. Self-directed antibodies and T cells are generated. The autoimmune process begins.
Ongoing gut permeability, persistent pathogen activity, continued exposure to cross-reactive antigens, vitamin D deficiency (which regulates T regulatory cell function), and chronic stress all maintain autoimmune activity after the initial trigger. Removing perpetuating factors often reduces disease activity even when the original trigger cannot be addressed.
The immune system cannot be suppressed
indefinitely without consequence.
At some point the cause must be faced.
What the System Gets Wrong
The standard treatment for autoimmune disease is suppression of the immune response. Corticosteroids, disease-modifying antirheumatic drugs (DMARDs), biologics, and immunosuppressants reduce the attack on self-tissue. For severe disease, this is often necessary and life-preserving. The problem is that it is almost universally offered as a permanent strategy, without parallel investigation of the triggers and perpetuating factors that could be addressed to reduce the immune system's need to attack in the first place.
A person diagnosed with Hashimoto's thyroiditis is typically started on levothyroxine to replace thyroid hormone and told they will be on it for life. The autoimmune attack on the thyroid, the actual disease process, is almost never investigated from the standpoint of what triggered and is maintaining it. Gut permeability, gluten sensitivity (which has a well-documented association with Hashimoto's), vitamin D deficiency, and specific pathogen triggers are rarely evaluated. The thyroid is managed. The immune dysregulation continues, sometimes progressing to additional autoimmune conditions as the underlying drivers remain active.
The evidence linking leaky gut to autoimmune initiation and perpetuation is extensive. Fasano's research on zonulin, the molecule that regulates intestinal permeability, demonstrated that zonulin is elevated before the onset of several autoimmune conditions and that its reduction correlates with disease activity reduction. This work is published in the highest-quality gastroenterology journals. It does not appear in the standard rheumatology or endocrinology workup. Gut assessment is not part of the autoimmune diagnostic process in conventional medicine.
The Autoimmune Protocol (AIP) diet is an elimination protocol specifically designed to reduce dietary triggers of autoimmune activity. It removes grains, dairy, legumes, nightshades, eggs, alcohol, and processed foods. Clinical studies in inflammatory bowel disease, Hashimoto's, and mixed connective tissue disease show meaningful reductions in inflammatory markers and symptom burden. Rheumatologists rarely discuss it. Endocrinologists rarely discuss it. The patient who asks about diet is often told it does not matter. The literature says otherwise.
Vitamin D regulates the production and function of T regulatory cells, the immune cells responsible for preventing self-directed immune attacks. Deficiency is documented in virtually every autoimmune condition studied. Geographic distribution of autoimmune diseases correlates with latitude and sun exposure, with higher rates in regions with less UV radiation. Optimal vitamin D levels for immune regulation, 60 to 80 ng/mL, are rarely achieved in standard care. Most patients with autoimmune conditions are at 20 to 40 ng/mL and receive supplementation at doses too low to move the needle significantly.
Biologic medications (TNF inhibitors, IL-6 inhibitors, B-cell depleting agents) are powerful tools with meaningful risks: increased infection risk, malignancy risk, cardiovascular effects, and rebound disease activity when discontinued. They are appropriate for severe, refractory disease. They are increasingly used as early treatment without comprehensive evaluation of what dietary, gut, environmental, and nutritional factors are maintaining the autoimmune activity. The question of whether a patient who eliminates gluten, restores gut integrity, optimizes vitamin D, and addresses toxin exposure still needs a biologic has rarely been asked before the biologic is prescribed.
Root Cause Map
Most people with autoimmune conditions can identify a period of significant stress, infection, dietary shift, or environmental change that preceded the onset of symptoms by months to years. The trigger is usually findable. The perpetuating factors are almost always addressable.
The immune system is responding
to something it was taught to fear.
Remove the teacher. Change the lesson.
Natural Restoration Toolkit
These interventions do not replace necessary medical management for active autoimmune disease. They address the upstream factors that maintain autoimmune activity and that standard care leaves entirely unaddressed. For many people, systematic implementation of these approaches reduces disease activity measurably and sometimes sustainably.
The AIP removes grains, dairy, legumes, nightshades (tomatoes, peppers, potatoes, eggplant), eggs, nuts, seeds, alcohol, processed foods, and refined sugar. It retains meat, fish, vegetables (excluding nightshades), fruit, and fermented foods. The goal is eliminating all common dietary triggers of gut permeability and immune activation simultaneously. Implement for 60 to 90 days minimum before evaluating. Systematic reintroduction after the elimination phase identifies specific triggers. Published clinical trials show significant inflammatory marker reduction in Hashimoto's and IBD.
The gut restoration protocol is not optional for autoimmune conditions. Intestinal permeability is both a trigger and a perpetuating factor for autoimmune disease. L-glutamine, zinc carnosine, probiotics, colostrum, and bone broth address the structural gut lining problem. Identifying and removing the dietary, medication, or microbial cause of permeability is equally important. See the Gut Health guide for the full protocol. Gut restoration in autoimmune conditions is often the single most impactful intervention and the most underused.
Target 60 to 80 ng/mL serum 25-OH vitamin D. For most adults this requires 5,000 to 10,000 IU daily with vitamin K2. Test before supplementing. Retest at 90 days. For active autoimmune disease, some practitioners target the higher end of this range under supervision. Vitamin D at optimal levels upregulates T regulatory cells that suppress self-directed immune attacks. This is the most broadly applicable single intervention for autoimmune conditions and the most consistently deficient variable in people with them.
Test first. Supplement based on results. Retest to confirm target reached.
At doses of 1.5 to 4.5mg, naltrexone modulates microglial activity and upregulates endogenous opioid production, which has immune regulatory properties. It has been studied in Crohn's disease, multiple sclerosis, lupus, and fibromyalgia with meaningful results in reducing inflammatory markers and symptom burden. Requires a prescription and compounding pharmacy for low-dose formulation. One of the most underutilized interventions in autoimmune medicine given its safety profile and mechanism of action.
Requires prescription. Not compatible with opioid therapy.
Heavy metals, mold mycotoxins, pesticide residues, and environmental chemicals all directly and indirectly drive immune dysregulation. Mold testing of the home environment (ERMI test) if symptoms worsen in specific locations. Heavy metal testing (hair analysis or provoked urine testing) if exposure history is relevant. Organic food where feasible to reduce pesticide load. Water filtration. These are not fringe interventions. They are load reduction on an immune system that is already overwhelmed.
EPA and DHA modulate the production of inflammatory cytokines that drive autoimmune tissue damage. They support the resolution pathway that should end inflammatory episodes. They also shift the ratio of inflammatory to anti-inflammatory prostaglandins in a direction that reduces autoimmune activity. Therapeutic dose for autoimmune conditions: 3 to 4g EPA plus DHA daily from high-quality fish oil. Effects build over 8 to 12 weeks and are sustained with continued use.
T regulatory cells that suppress self-directed immune attacks are produced and calibrated largely during sleep. Sleep deprivation reduces their number and function. Chronic sleep disruption is a direct driver of immune dysregulation and autoimmune activity. For people with autoimmune conditions where fatigue is already a dominant symptom, protecting sleep is both a quality of life issue and a direct immune therapy. See the Sleep guide for the full restoration protocol.
Chronic stress reduces T regulatory cell production, increases gut permeability, elevates pro-inflammatory cytokines, and activates the same immune pathways that drive autoimmune tissue damage. Stress management in the context of autoimmune disease is not a lifestyle suggestion. It is a direct immune intervention. Practices with documented immune effects: vagal breathing, meditation, MBSR, somatic therapy, and genuinely restorative social connection. These should be part of every autoimmune treatment protocol.
Real Questions
I have Hashimoto's. My TSH is normal on levothyroxine but I still feel terrible. Why?
Because levothyroxine replaces thyroid hormone. It does not stop the immune attack on the thyroid and it does not address the conversion problem that often accompanies Hashimoto's.
The autoimmune attack on the thyroid continues regardless of TSH normalization. As the attack progresses, the thyroid produces less hormone and the dose increases. Meanwhile, the downstream effects of ongoing thyroid inflammation, the fatigue, brain fog, weight resistance, and mood disruption, persist because the root cause is not being treated.
The second piece: levothyroxine provides T4, the inactive form of thyroid hormone. Conversion to T3, the active form, happens primarily in the liver and gut. People with gut dysbiosis, high inflammatory load, or cortisol dysregulation often have impaired T4-to-T3 conversion. The TSH looks normal because there is enough T4, but the cells are not receiving adequate active T3. Testing free T3 and reverse T3 alongside TSH reveals this pattern. Adding a T3-containing medication or addressing the conversion impairment produces symptom relief that T4 alone cannot.
My rheumatologist wants to start me on a biologic. I am scared of the side effects. Is there anything to try first?
Yes, if the disease activity is not immediately threatening or organ-damaging and if the foundational variables have not been genuinely addressed. The question to ask your rheumatologist is: have we ruled out and addressed dietary triggers, gut permeability, vitamin D deficiency, and environmental exposures before escalating to a biologic?
For conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis that are not yet causing irreversible joint damage, a 90-day intensive trial of AIP diet, gut restoration, vitamin D optimization to 60 to 80 ng/mL, and low dose naltrexone is a reasonable prior step. Some patients achieve remission or significant disease reduction that changes the biologic conversation. Others do not, in which case the biologic is clearly indicated.
The concern about side effects is legitimate. TNF inhibitors carry real infection and malignancy risks. They also carry real benefits for people with severe, progressive disease. The question is not whether they work. It is whether they are being recommended before less risky options have been genuinely tried. That is a question worth asking directly.
I have multiple autoimmune conditions. Is that unusual? How did this happen?
Multiple autoimmune conditions in one person is not unusual. It is a recognized pattern called polyautoimmunity, and it points toward a systemic immune dysregulation problem rather than multiple independent diseases.
Once the immune system has lost tolerance in one domain, the factors maintaining that loss, gut permeability, vitamin D deficiency, ongoing toxin or antigen exposure, persistent pathogen activity, stress-driven immune dysregulation, tend to produce additional tolerance failures over time. The second autoimmune condition is not bad luck. It is the same underlying mechanism finding a new target.
This framing is actually useful, not discouraging. It means all of the conditions share a common upstream driver. Addressing the upstream driver addresses all of them simultaneously. People who implement comprehensive root cause protocols for their primary autoimmune condition often report improvement in secondary conditions as well. The immune system does not compartmentalize by diagnosis. It responds to the overall regulatory environment.
My doctor said autoimmune disease has no cure and I will be managing it for life. Is that accurate?
It is accurate that most autoimmune conditions cannot be fully cured in the conventional medical sense of permanent remission after stopping all treatment. It is not accurate that nothing can be done beyond pharmaceutical management.
Documented remission is achieved in a meaningful subset of people with autoimmune conditions who make comprehensive dietary, gut, and lifestyle changes. The data is not large enough to quote reliable remission rates across conditions because this approach has not been studied at the scale of pharmaceutical trials. Individual case reports and small clinical studies, particularly for Hashimoto's, celiac disease, IBD, and early-stage RA, show meaningful and sometimes complete disease activity reduction that outlasts the intervention.
The more accurate framing may be: autoimmune disease is influenced by factors you can control. The degree of influence varies by condition, disease stage, and individual biology. Some people achieve remission. Most achieve meaningful reduction in disease activity. None of them achieve any of that without addressing the underlying drivers. That work is worth doing regardless of where the outcome lands.
I went gluten-free six months ago and my autoimmune symptoms improved significantly. My doctor says gluten cannot cause autoimmune disease. Who is right?
Your symptom experience is the primary data point and it is not in conflict with the literature, even if it is in conflict with your doctor's training.
Gluten's relationship to autoimmune disease extends well beyond celiac disease. Gluten activates zonulin, the molecule that regulates tight junction opening in the gut, in all humans to varying degrees. Elevated zonulin increases intestinal permeability. In genetically susceptible individuals, this permeability allows partially digested gliadin proteins to enter circulation and trigger immune responses that cross-react with human tissue antigens. This mechanism has been documented for Hashimoto's, type 1 diabetes, and neurological autoimmune conditions.
Non-celiac gluten sensitivity, a condition where gluten produces systemic immune and inflammatory effects without the specific celiac antibody pattern, is real and documented. Your improvement on a gluten-free diet is clinically meaningful regardless of whether you have a celiac diagnosis. The correct interpretation is not "gluten cannot affect autoimmunity." The correct interpretation is "gluten affects this person's autoimmune activity and removing it reduced that activity." That is useful clinical information.
The MAP Tool maps your situation to root cause. It does not guess. It follows the thread until it finds something real.
Start Your Map